Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options

Current Treatment Options in Neurology - United States
doi 10.1007/s11940-016-0422-5
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration

Journal of Neuroscience
Neuroscience
2016English

Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome

Frontiers in Neurology
Neurology
2017English

Progressive Supranuclear Palsy

2010English

Progressive Supranuclear Palsy

2020English

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-Pet Imaging?

Frontiers in Neurology
Neurology
2018English

Reduced Synaptic Density in Progressive Supranuclear Palsy and Corticobasal Syndrome, Revealed by [11c]ucb-J PET.

2020English

CoQ10 in Progressive Supranuclear Palsy

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2016English

Sleep Abnormalities in Progressive Supranuclear Palsy

Annals of Neurology
Neurology
1989English

Procerus Sign in Progressive Supranuclear Palsy

Neurology
Neurology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy